 The single most important prognostic factor in AML is cytogenetics , or the chromosomal structure of the leukemic cell . Certain cytogenetic abnormalities are associated with very good outcomes ( for example , the ( 15 ; 17 ) translocation in acute promyelocytic leukemia ) . About half of people with AML have " normal " cytogenetics ; they fall into an intermediate risk group . A number of other cytogenetic abnormalities are known to associate with a poor prognosis and a high risk of relapse after treatment . 
 The single most important prognostic factor in AML <a href='drop_aux' title='1'><mark>is</mark></a>cytogenetics , or the chromosomal structure of the leukemic cell . Certain cytogenetic abnormalities are associated with very good outcomes ( for example , the ( 15 ; 17 ) translocation in acute promyelocytic leukemia ) . About half of people with AML <a href='got' title='2'><mark>have</mark></a> " normal " cytogenetics ; they fall into an intermediate risk group . A number of other cytogenetic abnormalities are known to associate with a poor prognosis and a high risk of relapse after treatment . 
The single most important prognostic factor in AML cytogenetics , or the chromosomal structure of da leukemic cell . Certain cytogenetic abnormalities are associated wit very gud outcomes ( for example , tda( 15 ; 17 ) translocation in acute promyelocytic leukemia ) . About half of people wwidAML got " normal " cytogenetics ; they fall into an intermediate risk group . A number of other cytogenetic abnormalities are known to associate with a poor prognosis and a high risk of relapse after treatment .